Skip to main content

Animations

MJFF Publications

5571 - 5580 of 9036 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-04136-8
    Citation Count: 30
  • Summary Details
    OPEN
    Title: APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00411-x
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Parkinson's disease resting tremor severity classification using machine learning with resampling techniques
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2022.955464
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-022-01116-2
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.919778
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00400-0
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Targeting the inflammasome in Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.957705
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Using former carers’ expertise in peer support for carers of people with Parkinson’s Disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00381-0
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-20261-0
    Citation Count: 33
  • Summary Details
    OPEN
    Title: The impact of harmonization on radiomic features in Parkinson’s disease and healthy controls: A multicenter study
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2022.1012287
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.